Notice of Annual General Meeting/Proxy Form
Released
Released
Announcement PDF
VARISCAN MINES LIMITED
ACN 003 254 395
-----------------------------------------------------------------------------------------------NOTICE OF ANNUAL GENERAL MEETING
EXPLANATORY MEMORANDUM
PROXY FORM
------------------------------------------------------------------------------------------------
Date of Meeting
25 November 2015
Time of Meeting
2.00 pm (Sydney time)
Place of Meeting
HLB Mann Judd, Level 19, 207 Kent St, Sydney NSW 2000
This Notice of Meeting and Explanatory Memorandum should be read in their entirety. If you do not understand these
documents or are in any doubt as to how to deal with them, you should consult your stockbroker, solicitor, accountant or
other professional adviser immediately.
11345608.1
AAD JBH
NOTICE OF ANNUAL GENERAL MEETING
VARISCAN MINES LIMITED
ACN 003 254 395
NOTICE IS HEREBY GIVEN that the 29th Annual General Meeting (AGM) of the members of
Variscan Mines (the “Company”) will be held at HLB Mann Judd, Level 19, 207 Kent St, Sydney
NSW on Wednesday 25 November 2015 commencing at 2.00 pm (Sydney time).
The business to be considered at the meeting is set out below. This Notice of Meeting should be
read in conjunction with the accompanying Explanatory Memorandum, which contains information
in relation to each of the Resolutions. A Proxy Form also accompanies this Notice of Meeting.
ORDINARY BUSINESS
2015 Financial Statements
To receive the Reports of the Directors and Auditors, and the Financial Report for the year ended 30
June 2015.
Resolution 1 - Remuneration Report
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That the Remuneration Report of the Company for the year ended 30 June 2015 be
adopted.”
Resolution 2 – Re-Election of Mr Kwan Chee Seng as a Director
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
"That Mr Kwan Chee Seng, having retired as a director of the Company pursuant to clause
71 of the Company’s Constitution and, being eligible, and having offered himself for reelection, be re-elected as a director of the Company."
Resolution 3 – Re-Election of Dr Foo Fatt Kah as a Director
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
"That Dr Foo Fatt Kah, having retired as a director of the Company pursuant to clause 71 of
the Company’s Constitution and, being eligible, and having offered himself for re-election, be
re-elected as a director of the Company."
Resolution 4 – Election of Mr Michael Moore as a Director
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
"That Michael Moore, having retired as a director of the Company pursuant to clause 69 of
the Company’s Constitution and, being eligible, having offered himself for re-election, be
elected as a director of the Company."
2
NOTICE OF ANNUAL GENERAL MEETING
SPECIAL BUSINESS
Resolution 5 – Grant of Options to Managing Director, Gregory Jones
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That for the purposes of Section 208 of the Corporations Act and Listing Rule 10.11 and
for all other purposes, approval is given for the grant of 2,800,000 options to Greg Jones (or
his nominee) for nil consideration with an exercise price of 5 cents each, expiring 3 years
after the date of issue and otherwise on the terms and conditions described in the
Explanatory Memorandum which is attached to and forms part of this Notice.”
Resolution 6 – Grant of Options to Executive Director, Jack Testard
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That for the purposes of Section 208 of the Corporations Act and Listing Rule 10.11 and
for all other purposes, approval is given for the grant of 1,400,000 options to Jack Testard (or
his nominee) for nil consideration with an exercise price of 5 cents each, expiring 3 years
after the date of issue and otherwise on the terms and conditions described in the
Explanatory Memorandum which is attached to and forms part of this Notice.”
Resolution 7 – Grant of Options to Non-Executive Director, Patrick Elliott
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That for the purposes of Section 208 of the Corporations Act and Listing Rule 10.11 and
for all other purposes, approval is given for the grant of 1,000,000 options to Pat Elliott (or his
nominee) for nil consideration with an exercise price of 5 cents each, expiring 3 years after
the date of issue and otherwise on the terms and conditions described in the Explanatory
Memorandum which is attached to and forms part of this Notice.”
Resolution 8 – Grant of Options to Non-Executive Director, Kwan Chee Seng
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That for the purposes of Section 208 of the Corporations Act and Listing Rule 10.11 and
for all other purposes, approval is given for the grant of 1,500,000 options to Kwan Chee
Seng (or his nominee) for nil consideration with an exercise price of 5 cents each, expiring 3
years after the date of issue and otherwise on the terms and conditions described in the
Explanatory Memorandum which is attached to and forms part of this Notice.”
Resolution 9 – Grant of Options to Non-Executive Director, Foo Fatt Kah
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That for the purposes of Section 208 of the Corporations Act and Listing Rule 10.11 and
for all other purposes, approval is given for the grant of 1,000,000 options to Foo Fat Kah (or
his nominee) for nil consideration with an exercise price of 5 cents each, expiring 3 years
after the date of issue and otherwise on the terms and conditions described in the
Explanatory Memorandum which is attached to and forms part of this Notice.”
Resolution 10 – Grant of Options to Non-Executive Director, Michael Moore
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That for the purposes of Section 208 of the Corporations Act and Listing Rule 10.11 and
for all other purposes, approval is given for the grant of 1,000,000 options to Michael Moore
or his nominee) for nil consideration with an exercise price of 5 cents each, expiring 3 years
after the date of issue and otherwise on the terms and conditions described in the
Explanatory Memorandum which is attached to and forms part of this Notice.”
3
NOTICE OF ANNUAL GENERAL MEETING
Resolution 11 – Issue of Equity Securities up to an additional 10% of the Company’s Issued
Capital
To consider, and if thought fit, to pass the following as a special resolution:
”That, for the purposes of ASX Listing Rule 7.1A and for all other purposes, approval is
given for the issue of Equity Securities up to an additional10% of the issued capital of
the Company (at the time of issue), calculated in accordance with the formula
prescribed in ASX Listing Rule 7.1A.2 and on the terms and conditions set out in the
Explanatory Memorandum which is attached to and forms part of this Notice.”
BY ORDER OF THE BOARD
Ivo Polovineo
Company Secretary Date: 30 September 2015
IMPORTANT INFORMATION
The Explanatory Memorandum accompanying this Notice of Annual General Meeting is
incorporated in and comprises part of this Notice of Annual General Meeting, and should be read in
conjunction with this Notice of Annual General Meeting.
Shareholders are specifically referred to the Glossary in the Explanatory Memorandum which
contains definitions of capitalised terms used both in this Notice of Annual General Meeting and
the Explanatory Memorandum.
Voting Exclusions
Resolution 1
A vote on Resolution 1 must not be cast (in any capacity) by or on behalf of any of the following
persons:
(a)
(b)
a member of the Key Management Personnel, details of whose remuneration are included
in the Remuneration Report; or
a Closely Related Party of such a member.
However, a person described above may cast a vote on Resolution 1 if:
(c)
(d)
the person does so as a proxy appointed by writing that specifies how the proxy is to vote
on the proposed Resolution; and
the vote is not cast on behalf of a person described in paragraphs (a) or (b) above.
If a shareholder wishes to nominate the Chairman as their proxy for the purpose of Resolution 1
the shareholder can direct the Chairman to vote by marking one of the boxes for Resolution 1 on
the Proxy Form. If a shareholder appoints the Chairman as proxy or the Chairman of the meeting
is appointed as proxy by default but the shareholder does not mark a voting box for Resolution 1,
the shareholder will be taken to have expressly authorised the Chairman of the meeting to exercise
4
NOTICE OF ANNUAL GENERAL MEETING
the proxy in respect of Resolution 1 even though the item is connected with the remuneration of
Key Management Personnel.
The Chairman intends to vote all available proxies in favour of Resolution 1.
Resolution 5 to 10
The Company will disregard any votes in respect of each of these resolutions if they are cast by or
on behalf of a person who is named in the relevant resolution or an associate of that named person
as set out below:
Resolution 5 – Gregory Jones or his nominee
Resolution 6 – Jack Testard or his nominee
Resolution 7 – Patrick Elliott or his nominee
Resolution 8 – Kwan Chee Seng or his nominee
Resolution 9 – Foo Fatt Kah or his nominee
Resolution 10 – Michael Moore or his nominee
However the Company need not disregard a vote if:
(a)
it is cast by a person as proxy for a person who is entitled to vote, in accordance with the
directions on the relevant proxy form; or
(b)
it is cast by the person chairing the meeting as a proxy for a person who is entitled to vote, in
accordance with a direction on the proxy form to vote as the proxy decides.
Resolution 11
The Company will disregard any votes cast on Resolution 11 by:
(a)
A person who may participate in the proposed issue of Equity Securities and a person who
might obtain a benefit, except a benefit solely in the capacity of a holder of Shares, if the
resolution is passed; and
(b)
Any associate of those persons.
However, the Company need not disregard any vote by any such persons on Resolution 11 if:
(d)
(e)
It is cast by any of them as proxy for a person who is entitled to vote, in accordance with the
directions on the proxy form, or
It is cast by the person who is chairing the meeting as proxy for a person who is entitled to
vote, in accordance with a direction on the proxy form to vote as the proxy decides
Proxies
(a) Votes at the Annual General Meeting may be given personally or by proxy, attorney or
representative;
(b)
Each shareholder has a right to appoint one or two proxies;
(c)
A proxy need not be a shareholder of the Company;
(d)
If a shareholder is a company it must execute under its common seal or otherwise in
accordance with its constitution;
5
NOTICE OF ANNUAL GENERAL MEETING
(e)
Where a shareholder is entitled to cast two or more votes, the Shareholder may appoint two
proxies and may specify the proportion or number of votes each proxy is appointed to
exercise;
(f)
If a shareholder appoints two proxies, and the appointment does not specify the proportion or
number of the Shareholder’s votes, each proxy may exercise half of the votes. If a
shareholder appoints two proxies, neither proxy may vote on a show of hands;
(g)
A proxy must be signed by the Shareholder or his or her power of attorney who has not
received any notice of revocation of the authority. Proxies given by corporations must be
signed in accordance with the Company’s Constitution and the Corporations Act.
(h)
To be effective, proxy forms must be received by the Company’s share registry (Boardroom
Pty Limited) no later than 48 hours before the commencement of the Annual General
Meeting, that is no later than 2.00pm Sydney time on 23 November 2015. Any proxy form
received after that time will not be valid for the scheduled meeting.
Hand Delivery
By Mail
By Facsimile
Boardroom Pty Limited
Level 12,
225 George St
SYDNEY NSW 2000
Boardroom Pty Limited
GPO Box 3993
SYDNEY NSW 2001
(02) 9290 9655
Record date
The Company has determined, in accordance with regulation 7.11.37 of the Corporations
Regulations 2001 (Cth), that the holders of shares of the Company recorded in the Company’s
register as at 7pm (Sydney time) on 23 November 2015 shall, for the purposes of determining
voting entitlements at the Annual General Meeting, be taken to be held by the persons registered
as holding the shares at that time.
Corporate Representative
Any corporate Shareholder who has appointed a person to act as its corporate representative at
the Meeting should provide that person with a certificate or letter executed in accordance with the
Corporations Act authorising him or her to act as that company’s representative. The authority
may be sent to the Company and/or registry in advance of the Meeting or handed in at the Meeting
when registering as a corporate representative.
6
EXPLANATORY MEMORANDUM
This Explanatory Memorandum sets out information in
connection with the business to be considered at the
2015 Variscan Mines Limited Annual General Meeting.
ORDINARY BUSINESS
Financial Report
This item of business relates to the receipt and
adoption of the Company’s Financial Report for the
year ended 30 June 2015. The 2015 Annual Report
can be accessed on the Company’s website at
www.variscan.com.au.
Resolution 1
Adoption of Remuneration Report
The Remuneration Report is a section of the Directors
Report contained in the 2015 Annual Report. It is a
requirement of the Corporations Act that the Report be
provided to shareholders and voted upon by a vote
which is advisory only and does not bind the Directors
or the Company. However, if 25% or more of the votes
that are cast are voted against the adoption of the
Remuneration Report at two consecutive AGM’s,
shareholders will required to vote at the second of
those AGM’s on a resolution that another meeting be
held within 90 days at which all of the Company’s
Directors who are subject to a re-election requirement
must go up for re-election. At the 2014 AGM, 15.4% of
votes were cast against approval of the Remuneration
Report.
The Remuneration Report:
explains the Board’s policies relating to
remuneration of directors, secretaries and
executives of the Company;
discusses the relationship between such policies
and the Company’s performance;
provides details of any performance conditions
attached to such remuneration; and
sets out remuneration details for each director
and certain named executives.
Resolution 2
Re-election of Director - Mr Kwan Chee Seng
Pursuant to clause 71 of the Company’s Constitution, at
each annual general meeting of the Company 1/3 of all
the directors must retire from office and are eligible for
re-election.
The Company provides the following information
concerning Mr Kwan:
Biographical details
Mr Kwan was appointed a Director of the Company on
17 February 2009. Mr Kwan has investments in the
renewable sustainable energy, base metal resources
and the biotechnology businesses. He has extensive
experience in senior management and in business.
In March 2009, Mr Kwan launched his fund
management business with the incorporation of
Luminor Capital Pte Ltd and Luminor Pacific Fund 1 Ltd
(Fund 1). Recently he has launched Luminor Pacific
Fund 2 Ltd (Fund 2). The Fund 1 and Fund 2 have
been approved by the Economic Development Board of
Singapore under the Global Investor Program.
In December 2012, Mr Kwan acquired a major
shareholder stake in Singapore listed GRP Limited, and
in March 2013 he was appointed Executive Director of
GRP. He has previously served as Non-Executive
Director of Singapore listed companies Van der Horst
Energy Limited (from March 2008 to November 2011)
and Viking Offshore and Marine Ltd (from mid-2009 to
end 2010).
Details of relationships between the Candidate and
the Company
Mr Kwan is a non-executive Director of the Company
Details of relationships between the Candidate and
Directors of the Company
Not applicable
Other directorships held
Mr Kwan is Executive Director of Singapore listed GRP
Limited.
The term of office already served by Mr Kwan
Mr Kwan was appointed a Director of the Company on
17 February 2009.
The Directors (other than Mr Kwan) do not have an
interest in the outcome of Resolution 2 and recommend
that shareholders vote in favour of Resolution 2.
Resolution 3
Re-election of Director – Dr Foo Fatt Kah
Pursuant to clause 71 of the Company’s Constitution, at
each annual general meeting of the Company 1/3 of all
the directors must retire from office and are eligible for
re-election.
The Company provides the following information
concerning Dr Foo:
Biographical details
Dr Foo was appointed a Director of the Company on 7
October 2009. Dr Foo is the Managing Director and cofounder of Luminor Capital, a private equity fund
management company based in Singapore. He has
over 20 years’ experience in the investment banking,
fund management and advisory businesses spanning
Europe and Asia. He was previously Head of Asian
Equities for SG Securities Asia (the Asian Investment
Banking business for Societe Generale) covering 10
Asian countries ex-Japan. Since 2004 Dr Foo has been
active as an investor, overseeing investments in
Resources, Energy and Healthcare.
Dr Foo is qualified in Medicine (MB, B Ch, BAO) and
Business Administration (M.B.A.) from the Queen's
University, United Kingdom, with further continuing
education qualifications from Insead on Economic
Value Added (EVA) and International Project
Management. He has experience with listed companies
in Singapore, being previously Executive Director of
7
EXPLANATORY MEMORANDUM
CyberVillage Holdings Ltd and
Independent Director of PEC Ltd.
currently
Lead
Details of relationships between the Candidate and
the Company
Dr Foo is a non-executive Director of the Company
Details of relationships between the Candidate and
Directors of the Company
Not applicable
Other directorships held
Lead Independent Director of PEC Ltd.
The Directors (other than Mr Moore) do not have an
interest in the outcome of Resolution 4 and recommend
that shareholders vote in favour of Resolution 4.
SPECIAL BUSINESS
RESOLUTIONS 5 TO 10 – GRANT OF OPTIONS TO
DIRECTORS
In accordance with Resolutions 5 to 10 the Company
proposes to grant a total of 8,700,000 options to
Directors as follows:
The term of office already served by Dr Foo
Dr Foo joined the Board on 7 October 2009..
Gregory Jones
2,800,000
Jack Testard
1,400,000
The Directors (other than Dr Foo) do not have an
interest in the outcome of Resolution 3 and recommend
that shareholders vote in favour of Resolution 3.
Patrick Elliott
1,000,000
Kwan Chee Seng
1,500,000
Foo Fatt Kah
1,000,000
Resolution 4
Election of Director – Mr Michael Moore
Pursuant to clause 69 of the Company’s Constitution
the directors may at any time appoint any person as a
director. That person shall hold office until the end of
the next following annual general meeting and shall be
eligible for election at that meeting.
Michael Moore
1,000,000
The options are proposed to be issued for nil
consideration at an exercise of 5 cents each with an
expiry date 3 years after the date of issue. Each option
will entitle the optionholder to one ordinary fully paid
share when exercised.
The Company provides the following information
concerning Mr Moore:
Further terms and conditions of the options are set out
in the schedule to this Explanatory Memorandum.
Biographical details
Mr Moore was appointed a Non-Executive Director on 4
August 2015. Mr Moore is a mining engineer from the
Camborne School of Mines with over 15 years
operational and executive management experience
across a diverse range of commodities in Australia,
West Africa and France. He has previously held senior
and executive management roles with a number of
companies including Rock Australia Mining & Civil Pty
Ltd, Carnegie Minerals PLC and, more recently, with
ASX listed Montezuma Mining Company Ltd where he
was CEO. Mike’s experience includes mine feasibility
studies and mine operations, important in supporting
Variscan’s strategy to successfully advance its French
projects towards production.
The grant of options is designed to incentivise the
Directors by participating in the future growth and
prosperity of the Company through share ownership
and in recognition of the contribution made to the
Company by the Directors and their ongoing
responsibility.
Mr Moore has previously been a director of Carnegie
Minerals Gambia Ltd and Cordier Mines SAS (France).
Details of relationships between the Candidate and
the Company
Mr Moore is a non-executive Director of the Company
Details of relationships between the Candidate and
Directors of the Company
Not applicable
Other directorships held
Nil
The term of office already served Mr Moore
Mr Moore was appointed a Non-Executive Director on 4
August 2015.
Shareholder approval of the grant of options is being
sought for all purposes including for the purposes of
Chapter 2E of the Corporations Act and ASX Listing
Rule 10.11. If shareholder approval is given under ASX
Listing Rule 10.11, shareholder approval is not required
under ASX Listing Rule 7.1.
Shareholder Approval under Chapter 2E of the
Corporations Act
Resolutions 5 to 10 seek shareholder approval under
Chapter 2E of the Corporations Act.
Chapter 2E of the Corporations Act prohibits a public
company from giving a financial benefit to a related
party of the public company unless an exception
applies or shareholder approval is obtained. The
financial benefit must be given to the related party
within 15 months after shareholder approval is
obtained.
Section 228 of the Corporations Act defines “related
party” widely and incudes a director of a public
company and specified members of the director’s
family. Section 229 of the Corporation Act also defines
“financial benefit” widely and for the purpose of
8
EXPLANATORY MEMORANDUM
Resolutions 5 to 10 includes a public company granting
options to a director.
Requirements under
section
219
of
the
Corporations Act for the grant of Options to the
Non-Executive Directors
In accordance with section 219 of the Corporations Act,
the following information is given to shareholders:
If Resolutions 5 to 10 are passed, they will permit the
Company giving of a financial benefit to the following
persons:
Gregory Jones
Jack Testard
Patrick Elliott
Kwan Chee Seng
Foo Fatt Kah
Michael Moore
The Directors note that the ASX Corporate Governance
Council’s Corporate Governance Principles and
rd
Recommendations (3 edition) provide that it is
generally acceptable for non-executive directors to
receive securities as part of their remuneration to align
their interests with the interests of other security
holders. While the Corporate Governance Principles
and Recommendations suggest that non-executive
directors should not generally receive options with
performance hurdles attached or performance rights, it
is noted that there are no such hurdles attached to the
Options the subject of Resolutions 5 to 10.
Dilution effect on existing members’ interests
If all of the Options to be granted pursuant to
Resolutions 5 to 10 are exercised, the effect will be to
dilute the interests of existing shareholders. The table
below sets out the impact on the number of Shares and
Options on an undiluted and fully diluted basis:
All of whom, are Directors, and are related parties of
the Company.
The nature of the financial benefit is the grant of the
number of Options set out above for nil consideration,
exercisable at 5 cents and an expiry date three years
from the date of issue.
The Options will vest
immediately.
Other information
If the Company’s Shares are trading on ASX at a higher
price than the exercise price of the Options at the time
of exercise, the effect will be to give an immediate
financial benefit to the Directors at the time the Options
are exercised.
The Directors do not make any recommendation on
Resolutions 5 to 10 because of their personal interest in
the subject matter of the Resolutions.
All other information reasonably required by members
for the purposes of Chapter 2E of the Corporations Act
is set out below.
Additional Information regarding Resolutions 5 to
10 for the purpose of Chapter 2E of the
Corporations Act
Reasons for grant of Options
The Company has been fortunate to attract a highly
regarded management team, and given the relatively
small size of the Company it is important that the
Company retain its key people and, in particular, its
leadership.
Under the Company’s current circumstances, the
Directors consider that the proposed grant of the
Options is appropriate in order to retain those key
people, ensure that the remuneration being offered is
competitive and to provide an incentive to the Directors
to continue to play a key and integral role in the future
benefit of the Company and therefore increased
shareholder value.
Number of
Shares
Shares on issue at date of this
notice
306,447,930
Add Options already on issue
(upon exercise)
159,505,138
Total potential issued capital
465,953,068
Options to be granted to Directors
8,700,000
Potential issued capital fully
diluted
474,653,068
Dilution effect
1.83%
If all the Options are exercised, a further 8,700,000
Shares will be on issue and $435,000 (based on an
exercise price of $0.05 per Share) will be raised by the
Company and be utilised for working capital.
Trading History
The market price of the Company’s Shares during the
period the Options are issued and unexercised may be
one factor in determining whether or not the Directors
will exercise the Options. The Company’s Shares may
be trading on the ASX at a price which is higher than
the exercise price of the Options.
In these
circumstances, if the Directors then sell the Shares
arising from the exercise of the Options, they would
realise an immediate profit.
As at 29 September 2015, being the day before the
date of this Notice of Meeting, the Company’s closing
share price was $0.031. The highest, lowest and last
recorded market price of the Company’s shares quoted
on ASX during the 12 month period to 29 September
2015 (being the day immediately before the date of this
Notice) were:
Lowest
$0.011
Highest
$0.068
Last
$0.031
9
EXPLANATORY MEMORANDUM
Effect on Earnings
A-IFRS requires the Company to expense options
granted to directors with the expense being transferred
to an Options Expense Reserve. The amount to be
expensed and transferred to the Options Expense
Reserve in relation to Resolutions 5 to 10 is estimated
at $86,130 for the financial year ended 30 June 2016.
This amount will be transferred from the Option
Expense Reserve to Issued Capital on the exercise of
the Options. If the Options lapse, the amount will
remain as Options Expense Reserve.
Valuation of Options
The Options to be granted have been valued using the
Black, Scholes methodology as recommended in the
Accounting Standard AASB 2 “Share Based
Payments”.
The current Share and Option holdings of the Directors
and their associates are as follows:
Director
Shares Directly and
Indirectly Held
Options
G Jones
7,145,000
9,639,999
J Testard
200,000
3,500,000
P Elliott
5,488,805
4,736,460
CS Kwan
122,561,894
72,035,368
FK Foo
12,606,999
8,803,999
M Moore
-
-
1)
Further Information
The valuation methodology calculated the average
value of the Options in relation to Resolutions 5 to10 at
$0.0099 per option with a total value of $86,130. This
valuation assumes an exercise price of $0.05. In
calculating the above option valuation examples, the
following inputs were used in the valuation
methodology:
Apart from the information set out in this Explanatory
Statement there is no other information that is known to
the Company or any of its directors that is reasonably
required by shareholders to decide whether or not it is
in the Company’s interests to pass Resolutions 5 to 10.
Exercise Price
$0.05
Information required by the ASX Listing Rules for
Resolutions 5 to 10
Expected Life
3 years
Volatility
66.46%
Risk free rate (3 year Government
Bond Rate)
1.93%
Base share price
$0.031
Directors Remuneration and Equity holdings in the
Company
Listing Rule 10.11 requires shareholder approval for an
issue of equity securities to a related party. Approval is
therefore being sought for the proposed grant of
Options to Directors.
Listing Rule 10.13 requires this Notice of Meeting to
include the following specified information in relation to
the Options to be granted to Directors:
a)
In addition to the Options proposed to be granted,
effective 1 July 2015, Mr Jones will receive $281,284
per annum pursuant to his employment agreement with
Company, Dr Testard will receive the equivalent of Euro
65,532 per annum pursuant to his employment
agreement with Company, the Chairman (Mr Elliott) will
receive Directors fees of $50,000 per annum and NonExecutive Directors (Messrs Kwan,Foo and Moore,) will
each receive $36,000 per annum.
The Directors are entitled to reimbursement of all
reasonable travelling, accommodation and other
expenses that they properly incur in attending meetings
of Directors or any meetings of committees of Directors,
in attending meetings of shareholders or in connection
with the business of the Company.
The maximum number of securities to be issued to
the Directors is 8,700,000 Options. The allocation
of the Options and valuations are as follows:
Director
Number of
Options
Valuation of
Options
G Jones
2,800,000
$27,720
J Testard
1,400,000
$13,860
P Elliott
1,000,000
$9,900
CS Kwan
1,500,000
$14,850
FK Foo
1,000,000
$9,900
M Moore
1,000,000
$9,900
b)
No funds will be raised by the grant of the options
as they are being granted for no consideration.
c)
Share your feedback
Discover